These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19284285)

  • 21. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
    Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of the Enzygnost anti-EBV/IgG for the determination of the Epstein-Barr virus immune status in pediatric patients.
    Kleines M; Scheithauer S; Ritter K; Häusler M
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):247-9. PubMed ID: 16545933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of slides for Epstein-Barr virus diagnosis by indirect immunofluorescence].
    Pérez GR; Taborda MA; Toffi A; Palonsky M; Pagotto M; Gardiol DN; Giri AA
    Medicina (B Aires); 2005; 65(4):315-20. PubMed ID: 16193709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
    Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
    J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology of Epstein-Barr virus (EBV) infection and EBV-associated diseases].
    Maeda A; Sato T; Wakiguchi H
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():609-12. PubMed ID: 16615544
    [No Abstract]   [Full Text] [Related]  

  • 29. [The purification and application of Epstein-Barr virus gp125].
    Wang G; Pi G; Gu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic study of Epstein-Barr virus serologic assays following acute infection.
    Rea TD; Ashley RL; Russo JE; Buchwald DS
    Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of immunofluorescence assay and multiplexed microparticle-based immunoassay for detecting Epstein-Barr virus viral capsid antigen antibodies.
    Zeytinoglu A; Altuglu I; Karatas E; Yazan Sertoz R
    J Virol Methods; 2008 Mar; 148(1-2):300-2. PubMed ID: 18215427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status.
    Martins TB; Litwin CM; Hill HR
    Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients].
    Lauzurica R; Frías C; Bayés B; Ausina V; Romero R
    Nefrologia; 2005; 25(2):185-90. PubMed ID: 15912656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.
    Sakamoto K; Seeley JK; Lindsten T; Sexton J; Yetz J; Ballow M; Purtilo DT
    J Immunol; 1982 Feb; 128(2):904-7. PubMed ID: 6274962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
    Geser A; Brubaker G; Olwit GW
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.